+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Therapeutic Area Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
Forecasting in Oncology Course - Product Thumbnail Image

Forecasting in Oncology Course

  • Training
  • 3 Hours
  • Global
Pipeline of Mesothelin-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Mesothelin-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
Pipeline of c-Met-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of c-Met-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
Pipeline of Her3-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Her3-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
Pipeline of EpCAM-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of EpCAM-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
Pipeline of Nectin-4-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Nectin-4-Targeted Immunotherapies

  • Report
  • November 2025
  • Global
From
Pipeline of CD73 Inhibitors - Product Thumbnail Image

Pipeline of CD73 Inhibitors

  • Report
  • November 2025
  • Global
From
Loading Indicator

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs. Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more